We are live on ! Find out more
BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

Back to rankings

48 hedge funds and large institutions have $3.83M invested in Biotech Acquisition Company Warrant in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $3.8M → $3.83M (+$38.3K)

6% less funds holding

Funds holding: 51 → 48 (-3)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
48
Holders Change
-3
Holders Change %
-5.88%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
4
Closed
4
Calls
$5.82M
Puts
–
Net Calls
+$5.82M
Net Calls Change
+$98K

Top Buyers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
+$2.34K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$395
3
MC
Meteora Capital
Florida
+$196
4
RA
Ramius Advisors
New York
+$59

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.36K
2
BCM
Basso Capital Management
Connecticut
-$1K
3
OCAM
Owl Creek Asset Management
New York
-$1K
4
PCM
Prelude Capital Management
New York
-$1K
5
UBS Group
UBS Group
Switzerland
-$960
Name Holding Trade Value Shares
Change 		Change in
Stake
KPF
26
K2 Principal Fund
Ontario, Canada
$3.91K +$2.34K +61,201 New
WA
27
Whitebox Advisors
Minnesota
$3.67K – – –
Jane Street
28
Jane Street
New York
$3.36K – – –
CP
29
Centerbridge Partners
New York
$3.19K – – –
CCA
30
Castle Creek Arbitrage
Colorado
$3.11K – – –
CS
31
Clear Street
New York
$3K -$16 -418 -0.9%
CCM
32
Context Capital Management
California
$3K – – –
Walleye Trading
33
Walleye Trading
New York
$2.56K – – –
State of Wisconsin Investment Board
34
State of Wisconsin Investment Board
Wisconsin
$2.4K – – –
Citadel Advisors
35
Citadel Advisors
Florida
$2.28K -$1.36K -35,689 -50%
WAM
36
Wolverine Asset Management
Illinois
$2.24K – – –
SSA
37
Schonfeld Strategic Advisors
New York
$1.92K – – –
AA
38
AQR Arbitrage
Connecticut
$1.69K – – –
MC
39
Meteora Capital
Florida
$1.6K +$196 +5,128 +26%
PFM
40
Privium Fund Management
Netherlands
$1.27K – – –
AA
41
Ancora Advisors
Ohio
$1K – – –
CC
42
Centiva Capital
New York
$989 – – –
BCM
43
BCK Capital Management
Connecticut
$867 – – –
OAC
44
OMERS Administration Corp
Ontario, Canada
$799 – – –
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$660 +$395 +10,328 New
Bank of America
46
Bank of America
North Carolina
$634 – – –
UBS Group
47
UBS Group
Switzerland
$4 -$960 -25,136 -100%
PCM
48
Prelude Capital Management
New York
– -$1K -18,731 Closed
BCM
49
Basso Capital Management
Connecticut
– -$1K -12,854 Closed
OCAM
50
Owl Creek Asset Management
New York
– -$1K -10,000 Closed
1
2

BIOTW Hedge Fund Activity: Q4 2022 in Review

48 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Warrant (BIOTW) for Q4 2022, worth a combined $3.83M — up 1% from $3.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BIOTW and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was K2 Principal Fund, opening a new position worth an estimated $2.34K. The largest seller was Citadel Advisors, cutting an estimated $1.36K.

  • 48 institutional investors held Biotech Acquisition Company Warrant (BIOTW) as of Q4 2022, down from 51 in Q3 2022.
  • Funds reported $3.83M of Biotech Acquisition Company Warrant stock for Q4 2022, up 1% quarter-over-quarter.
  • 2 funds opened new Biotech Acquisition Company Warrant positions in Q4 2022 and 4 closed out, a net change of -2 holders.
  • The largest Biotech Acquisition Company Warrant buyer in Q4 2022 was K2 Principal Fund, an estimated $2.34K added.
  • The largest Biotech Acquisition Company Warrant seller in Q4 2022 was Citadel Advisors, an estimated $1.36K sold.

Based on aggregated 13F filings for Q4 2022.